Growth Metrics

Conmed (CNMD) EBIAT (2016 - 2020)

Historic EBIAT for Conmed (CNMD) over the last 11 years, with Q4 2020 value amounting to $24.1 million.

  • Conmed's EBIAT rose 6165.54% to $24.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $9.5 million, marking a year-over-year decrease of 6674.59%. This contributed to the annual value of $47.1 million for FY2025, which is 6446.61% down from last year.
  • Conmed's EBIAT amounted to $24.1 million in Q4 2020, which was up 6165.54% from $6.8 million recorded in Q3 2020.
  • Conmed's EBIAT's 5-year high stood at $46.7 million during Q4 2017, with a 5-year trough of -$27.4 million in Q2 2020.
  • Over the past 5 years, Conmed's median EBIAT value was $6.8 million (recorded in 2016), while the average stood at $7.5 million.
  • Per our database at Business Quant, Conmed's EBIAT skyrocketed by 59612.4% in 2017 and then tumbled by 58112.38% in 2020.
  • Over the past 5 years, Conmed's EBIAT (Quarter) stood at $6.7 million in 2016, then skyrocketed by 596.12% to $46.7 million in 2017, then plummeted by 66.48% to $15.7 million in 2018, then dropped by 4.6% to $14.9 million in 2019, then surged by 61.66% to $24.1 million in 2020.
  • Its EBIAT was $24.1 million in Q4 2020, compared to $6.8 million in Q3 2020 and -$27.4 million in Q2 2020.